Guus A.M.S. van Dongen

Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients

Marc C. Huisman, C. René Leemans, Dario Neri, 2013, The Journal of Nuclear Medicine.

Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients

Ronald Boellaard, Jan C. Roos, Jonas A. Castelijns, 2009, Journal of Nuclear Medicine.

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

Alexander Staab, Remco de Bree, G. Giaccone, 2006, Clinical Cancer Research.